Semaglutide doesn’t have a long list of drugs you absolutely cannot combine it with, but several medications and substances interact with it in ways that require dose adjustments, closer monitoring, or changes in timing. The biggest concern is that semaglutide slows how quickly your stomach empties, which can change how your body absorbs other pills you take by mouth. Beyond that, certain medical conditions rule out semaglutide entirely.
Who Should Not Take Semaglutide at All
Semaglutide is contraindicated if you or a close family member has a history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN2), which causes tumors in multiple glands. In animal studies, drugs in this class caused thyroid tumors, and while the risk in humans isn’t confirmed, the concern is serious enough that it’s a hard stop.
Insulin and Sulfonylureas
This is the interaction most likely to cause a noticeable problem. When you add semaglutide to insulin or a sulfonylurea (common diabetes pills that push your pancreas to release more insulin), the combined blood-sugar-lowering effect can tip you into hypoglycemia. In clinical trials, 17% to 30% of patients on semaglutide plus insulin or a sulfonylurea experienced symptomatic low blood sugar episodes.
If you’re starting semaglutide and already take insulin, guidelines from the American College of Cardiology recommend reducing your insulin dose by about 20% upfront when your blood sugar is already well controlled. Your doctor will likely taper your sulfonylurea as well. The key point: don’t start semaglutide without a plan to adjust these other medications at the same time.
How Semaglutide Affects Other Oral Medications
Semaglutide slows gastric emptying, meaning food and pills sit in your stomach longer than usual. For most drugs, this doesn’t change how much medication your body ultimately absorbs, but it can change when peak levels hit your bloodstream and how high those peaks are. That distinction matters most for medications where even small shifts in blood levels can cause problems.
Warfarin
Warfarin (a blood thinner) has a very narrow window between an effective dose and a dangerous one. No initial dose change is needed when starting semaglutide, but more frequent INR monitoring is recommended. INR is the blood test that measures how quickly your blood clots. If semaglutide shifts your warfarin absorption enough to push your INR out of range, you could face bleeding risks or lose clot protection.
Levothyroxine
If you take levothyroxine for an underactive thyroid and you’re starting the oral tablet form of semaglutide (Rybelsus), this is an important one. When the two are taken at the same time, the effective dose of levothyroxine may need to increase by as much as 33%. A practical fix: take your levothyroxine at bedtime instead of in the morning, which avoids the interaction entirely. Either way, your thyroid levels should be rechecked after starting semaglutide.
Oral Contraceptives
This is one interaction people worry about that turns out to be a non-issue. A clinical trial in 25 women found that oral semaglutide did not affect the absorption of a standard combination birth control pill. Total exposure and peak levels of both the estrogen and progestin components stayed within normal range. Your birth control should work the same.
Timing Rules for Oral Semaglutide
If you take the injectable forms (Ozempic or Wegovy), timing with other medications is less of a concern because the drug enters your bloodstream through the injection site, not your gut. But Rybelsus, the oral tablet, has strict timing requirements that affect everything else you take by mouth.
The FDA labeling is specific: take Rybelsus first thing in the morning with no more than 4 ounces of plain water, then wait at least 30 minutes before eating, drinking anything else, or taking any other oral medication. Waiting less than 30 minutes or taking it alongside food or other pills reduces how much semaglutide your body absorbs. Waiting longer than 30 minutes actually increases absorption. This means your entire morning medication routine may need to be restructured around that 30-minute window.
Alcohol
Alcohol isn’t formally contraindicated with semaglutide, but there are real reasons to be cautious. The combination raises the risk of low blood sugar, especially if you also take insulin or sulfonylureas, because alcohol independently suppresses your liver’s ability to release glucose.
The bigger concern is pancreatitis. Heavy alcohol use is one of the most common causes of pancreatitis, and while semaglutide itself hasn’t been shown to significantly increase pancreatitis risk, Cleveland Clinic advises that patients with a history of excess alcohol use should stop drinking before starting the medication. Interestingly, semaglutide appears to reduce alcohol cravings in many people by affecting reward pathways in the brain, which may make cutting back easier than expected.
NSAIDs and Kidney Stress
Common pain relievers like ibuprofen and naproxen (NSAIDs) aren’t specifically prohibited with semaglutide, but the combination deserves attention, particularly if you’re prone to dehydration. Semaglutide commonly causes nausea, vomiting, and diarrhea, especially in the first weeks, and that fluid loss alone can strain your kidneys. Adding NSAIDs, which reduce blood flow to the kidneys on their own, compounds the problem.
Post-marketing safety reports for drugs in the same class found that nearly all cases of acute kidney injury involved additional risk factors: dehydration from GI side effects, use of kidney-stressing drugs, or both. Blood pressure medications that act on the renin-angiotensin system (ACE inhibitors and ARBs) add another layer of kidney risk when dehydration is present. If you’re in the early dose-escalation phase and experiencing significant nausea or vomiting, it’s worth switching to acetaminophen for pain instead of reaching for ibuprofen.
Pancreatitis History
If you’ve had pancreatitis before, the question of whether to take semaglutide is more nuanced than it used to be. Older prescribing caution suggested avoiding GLP-1 drugs in these patients, but newer data paints a different picture. A large database study found that people with a history of acute pancreatitis who used semaglutide had a recurrence rate of about 10%, compared to roughly 27% to 41% for non-users. This doesn’t mean semaglutide prevents pancreatitis, but it does suggest the drug doesn’t meaningfully increase recurrence risk and may even be associated with a lower one.
That said, if you develop severe abdominal pain while on semaglutide, especially pain that radiates to your back, it needs evaluation. The medication should be stopped if pancreatitis is confirmed.